Article Details
Retrieved on: 2019-11-22 05:56:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>TheStreet lowered shares of OptimizeRx (NASDAQ:OPRX) from a c rating to a d+ rating in a research report report published on Wednesday, ...</div>
Article found on:
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here